The emergence of mcr-1-mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae in domestic and imported turkey meat in the Czech Republic 2017-2018

. 2020 Feb ; 65 (1) : 211-216. [epub] 20190417

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid31001764

Grantová podpora
NV 18-09-00254 Ministerstvo Zdravotnictví Ceské Republiky

Odkazy

PubMed 31001764
DOI 10.1007/s12223-019-00709-z
PII: 10.1007/s12223-019-00709-z
Knihovny.cz E-zdroje

We investigated the occurrence of plasmid-mediated colistin resistance in Enterobacteriaceae in turkey meat produced in the Czech Republic as well as in turkey meat imported into the Czech Republic from other European Union countries. Seventeen samples of raw turkey meat from the Czech Republic (n = 4), Hungary (n = 2), Poland (n = 6) and Germany (n = 5) were cultured in peptone water at 37 °C overnight and the enriched cultures were tested for the presence of mcr-1-5 genes. PCR-positive enriched cultures were inoculated onto selective agar with colistin (3.5 mg/L). A minimal inhibitory concentration (MIC) of colistin was determined by using the broth microdilution method in PCR-positive isolates. In addition, a macrorestriction analysis was performed using XbaI endonuclease. Of 17 meat samples, 12 samples from Poland (6/6), Germany (3/5) and the Czech Republic (3/4) proved positive for the presence of the mcr-1 gene. Forty-two isolates carrying the mcr-1 gene were obtained: Escherichia coli (n = 39) revealing 32 distinct XbaI profiles and Klebsiella pneumoniae (n = 3) with 2 distinct XbaI profiles. The minimal inhibitory concentration (MIC) of the mcr-1 positive isolates was as follows: 4 mg/L (n = 28), 8 mg/L (n = 12), 32 mg/L (n = 1) and 64 mg/L (n = 1). The high prevalence (70.6%; 12/17 samples) of mcr-1-mediated colistin-resistant Enterobacteriaceae found in the turkey meat samples analysed in this study, builds on previously published evidence that poultry, and their products, represent a substantial risk for the dissemination of plasmid-mediated colistin resistance in Europe.

Zobrazit více v PubMed

PLoS One. 2016 Jul 25;11(7):e0159863 PubMed

Lancet Infect Dis. 2016 Feb;16(2):144-5 PubMed

J Antimicrob Chemother. 2016 Aug;71(8):2331-3 PubMed

Euro Surveill. 2016;21(9):30155 PubMed

Euro Surveill. 2016;21(9):30149 PubMed

Int J Antimicrob Agents. 2015 Sep;46(3):297-306 PubMed

Front Microbiol. 2018 Jun 12;9:1217 PubMed

Vet Microbiol. 2018 Jan;213:42-46 PubMed

Euro Surveill. 2016 Jul 7;21(27): PubMed

Klin Mikrobiol Infekc Lek. 2017 Jun;23(2):58-60 PubMed

Antimicrob Resist Infect Control. 2017 Aug 18;6:83 PubMed

Antimicrob Agents Chemother. 2017 Oct 24;61(11): PubMed

Lancet Infect Dis. 2016 Feb;16(2):161-8 PubMed

Int J Food Microbiol. 2017 Dec 18;263:67-73 PubMed

J Antimicrob Chemother. 2016 Aug;71(8):2338-40 PubMed

mBio. 2017 Aug 15;8(4): PubMed

J Antimicrob Chemother. 2017 Dec 1;72(12):3317-3324 PubMed

Euro Surveill. 2017 Aug 3;22(31):null PubMed

Res Vet Sci. 2016 Apr;105:134-5 PubMed

J Antimicrob Chemother. 2016 Aug;71(8):2300-5 PubMed

Euro Surveill. 2016;21(6):null PubMed

Euro Surveill. 2015;20(49):null PubMed

Front Microbiol. 2018 Aug 17;9:1880 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...